Detalhe da pesquisa
1.
Broad sarbecovirus neutralization by a human monoclonal antibody.
Nature
; 597(7874): 103-108, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34280951
2.
Rapid development of broadly influenza neutralizing antibodies through redundant mutations.
Nature
; 516(7531): 418-22, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25296253
3.
Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.
Lancet Reg Health Eur
; 1: 100013, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173621
4.
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody.
bioRxiv
; 2021 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851169
5.
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients.
Nat Med
; 25(9): 1402-1407, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501610
6.
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.
Science
; 333(6044): 850-6, 2011 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21798894